Related Experiment Video
Updated: Oct 25, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Challenges to Building a Gene Variant Commons to Assess Hereditary Cancer Risk: Results of a Modified Policy Delphi
Mary A Majumder1, Matthew L Blank1, Janis Geary2
1Center for Medical Ethics and Health Policy, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77005, USA.
Developing a comprehensive cancer gene variant commons is crucial for understanding hereditary cancer risk. Addressing policy issues in data sharing, privacy, and equity is essential for its success.
Area of Science:
- Genetics
- Bioinformatics
- Public Health Policy
Background:
- Clinical interpretation of hereditary cancer risk variants necessitates pooled genetic data resources.
- Existing initiatives face challenges due to unresolved policy issues in data sharing.
Purpose of the Study:
- To identify and analyze critical policy issues impacting the development of a cancer gene variant commons.
- To explore policy options across five key domains: incentives, financial sustainability, privacy, equity, and data quality.
Main Methods:
- A modified policy Delphi process involving diverse stakeholder experts.
- Analysis of policy issues and options generated by Delphi participants.
Main Results:
- Identified policy challenges in five critical domains for establishing a cancer gene variant commons.
- Generated actionable policy options to facilitate data sharing and resource development.
Conclusions:
- Addressing policy domains like incentives, privacy, and equity is vital for an effective cancer gene variant commons.
- This work provides a foundation for further policy evaluation to improve hereditary cancer research and patient care.
More Related Videos
05:53Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
Related Concept Videos
Cancer Prevention
Some...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mutagenicity and Carcinogenicity
Genetic Variation
Genes exist in different versions called alleles,...